Using Technology to Track Pain and Pain-related Outcomes

NCT ID: NCT04267588

Last Updated: 2025-06-29

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-08-10
• Study Completion Date: 2026-06-30

Brief Summary

Persistent pain is a public health epidemic. The current protocol seeks to develop technology to aid patients' tracking of patients' pain, medications and pain-related variables. The investigators seek to talk with patients in co-investigator's clinic to solicit feedback, as well as pilot test the technology with pain patients.

Detailed Description

Chronic pain affects over 100 million Americans, costs the US over $630 billion annually, and reduces quality of life. It is among the most clinically challenging and financially burdensome conditions facing clinicians and healthcare organizations. Sleep disturbance is common in chronic pain conditions with some studies reporting a prevalence as high as 70%-88%. Psychiatric disorders, including substance abuse and mood disorders are prevalent in chronic pain and are associated with impairment and decreased quality of life. Sleep is increasingly recognized as a critical regulator of mental health. Taken together, epidemiological, cross-sectional, and prospective studies support the hypothesis that insomnia, chronic pain, and depression are mutually interacting, each increasing the risk for the emergence and/or exacerbation of the other. The gold standard of chronic pain management is multidisciplinary pain treatment (MPT), but patients rarely receive MPT secondary to limited access and a severe shortage of pain management specialists. Thus, there is an urgent need for empirically supported, cost-effective multidisciplinary pain self-management options that are accessible to patients and trusted by primary and tertiary care providers. To address this problem, the investigators' group in collaboration with the Johns Hopkins Technology Innovation Center (TIC) has developed a mobile chronic pain, medication and symptom tracking digital technology platform designed to eventually support multidisciplinary pain treatment by enhancing patient-provider communication and delivering comprehensive, personalized, interactive evidence-based pain management strategies. The investigators' App (version 1.3) is currently able to collect self-report data (i.e., pain; sleep; mood; catastrophizing; stress; pain flares) and continuous, passively collected wearable biosensor data (i.e., heart rate; breathing; sleep; heart rate variability/stress). The investigators propose a prospective, observational proof of concept study to demonstrate feasibility and adherence while establishing the psychometric properties of a mobile pain App and to compare these data with passively collected physiological data and laboratory indices of pain in patients with chronic low back pain (CLBP).

Conditions

Pain, Chronic

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Navio App

The investigators propose to collect self-report and passively collected biological data and evaluate participants' relation to clinical and laboratory pain as well as patients' willingness to use and level of comfort with the mobile pain management digital platform and wearable biosensors. Eligible participants will be consented, given two biosensors (i.e., Apple Watch Series 1 with KardiaBand; Spire), a sleep monitoring device (actigraph watch), and a mobile app enabled smartphone, then trained on how to use the app (and device if appropriate) and biosensors. Participants will keep medications constant and not have any new pain treatment procedures over the course of the study period and 2 weeks prior to starting the study.

Navio Mobile App

Intervention Type: OTHER

Participants will use the Navio Mobile App to track participants' pain and pain treatment

Interventions

Navio Mobile App

Participants will use the Navio Mobile App to track participants' pain and pain treatment

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• ≥ 21 years of age
• Pain duration > 3 months
• Average pain level of >3 out of 10 (0=no pain; 10=worst pain imaginable)
• English fluency
• Are not scheduled to undergo any medical procedures during the course of the study
• Have a physician-confirmed medical diagnosis associated with chronic pain
• Are willing to comply with the study protocol and give written informed consent. Patients taking non-narcotic analgesics must be on a stable dose one month prior to participation.

Exclusion Criteria

• Delirium, dementia, or cognitive impairment (i.e., Mini Mental State Exam score <24)
• Unstable major psychiatric disorder or history of schizophrenia
• Beck Depression Inventory score >30 or report of suicidal ideation
• Active substance abuse;
• Refusal to provide access to relevant medical record information.

• Minimum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

PainCare, LLC

UNKNOWN

Sponsor Role: collaborator

Johns Hopkins University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Luis F Buenaver, Ph. D

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Locations

Behavioral Medicine Research Lab

Baltimore, Maryland, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Luis F Buenaver, PhD

Role: CONTACT

lbuenav1@jhmi.edu

410-550-7000

Luis F Buenaver, Ph. D

Role: CONTACT

lbuenav1@jhmi.edu

410-550-7986

Facility Contacts

Katie Dunnock

Role: primary

410-550-6165

Other Identifiers

IRB00196831

Identifier Type: -

Identifier Source: org_study_id